Victrex (LON:VCT) Rating Reiterated by Peel Hunt
Peel Hunt reiterated their hold rating on shares of Victrex (LON:VCT) in a research report report published on Monday, ThisIsMoney.Co.Uk reports.
VCT has been the topic of several other research reports. HSBC cut their target price on Victrex from GBX 2,520 ($32.93) to GBX 2,200 ($28.75) and set a hold rating on the stock in a research report on Monday, May 20th. Liberum Capital restated a buy rating on shares of Victrex in a research report on Thursday, August 22nd. JPMorgan Chase & Co. cut their target price on Victrex from GBX 2,300 ($30.05) to GBX 2,150 ($28.09) and set a neutral rating on the stock in a research report on Friday, July 5th. Barclays upgraded Victrex to an equal weight rating and set a GBX 2,020 ($26.39) target price on the stock in a research report on Wednesday, August 21st. Finally, Stifel Nicolaus assumed coverage on Victrex in a research report on Monday, May 20th. They set a buy rating and a GBX 2,255 ($29.47) target price on the stock. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. The company currently has an average rating of Hold and an average price target of GBX 2,284.09 ($29.85).
Shares of Victrex stock opened at GBX 2,172 ($28.38) on Monday. Victrex has a one year low of GBX 1,813.68 ($23.70) and a one year high of GBX 3,434 ($44.87). The stock’s 50-day moving average is GBX 2,008.52 and its 200 day moving average is GBX 2,153.89. The firm has a market cap of $1.88 billion and a price-to-earnings ratio of 18.89.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
Read More: What is the Bid-Ask Spread?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.